Loading...

Fielmann AG

FLMNYPNK
Healthcare
Medical - Instruments & Supplies
$9.94
$0.00(0.00%)
U.S. Market is Open • 13:00

Fielmann AG Fundamental Analysis

Fielmann AG (FLMNY) shows moderate financial fundamentals with a PE ratio of 18.13, profit margin of 8.37%, and ROE of 21.20%. The company generates $2.3B in annual revenue with moderate year-over-year growth of 7.56%.

Key Strengths

ROE21.20%
PEG Ratio0.73

Areas of Concern

No major concerns flagged.
We analyze FLMNY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 53.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
53.9/100

We analyze FLMNY's fundamental strength across five key dimensions:

Efficiency Score

Weak

FLMNY struggles to generate sufficient returns from assets.

ROA > 10%
8.20%

Valuation Score

Excellent

FLMNY trades at attractive valuation levels.

PE < 25
18.13
PEG Ratio < 2
0.73

Growth Score

Excellent

FLMNY delivers strong and consistent growth momentum.

Revenue Growth > 5%
7.56%
EPS Growth > 10%
34.25%

Financial Health Score

Excellent

FLMNY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.57
Current Ratio > 1
1.15

Profitability Score

Weak

FLMNY struggles to sustain strong margins.

ROE > 15%
21.20%
Net Margin ≥ 15%
8.37%
Positive Free Cash Flow
No

Key Financial Metrics

Is FLMNY Expensive or Cheap?

P/E Ratio

FLMNY trades at 18.13 times earnings. This indicates a fair valuation.

18.13

PEG Ratio

When adjusting for growth, FLMNY's PEG of 0.73 indicates potential undervaluation.

0.73

Price to Book

The market values Fielmann AG at 3.70 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.70

EV/EBITDA

Enterprise value stands at 6.00 times EBITDA. This is generally considered low.

6.00

How Well Does FLMNY Make Money?

Net Profit Margin

For every $100 in sales, Fielmann AG keeps $8.37 as profit after all expenses.

8.37%

Operating Margin

Core operations generate 13.29 in profit for every $100 in revenue, before interest and taxes.

13.29%

ROE

Management delivers $21.20 in profit for every $100 of shareholder equity.

21.20%

ROA

Fielmann AG generates $8.20 in profit for every $100 in assets, demonstrating efficient asset deployment.

8.20%

Following the Money - Real Cash Generation

Operating Cash Flow

Fielmann AG generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Fielmann AG generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

FLMNY converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

18.13

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.73

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.70

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.52

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.57

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.21

vs 25 benchmark

ROA

Return on assets percentage

0.08

vs 25 benchmark

ROCE

Return on capital employed

0.17

vs 25 benchmark

How FLMNY Stacks Against Its Sector Peers

MetricFLMNY ValueSector AveragePerformance
P/E Ratio18.1329.77 Better (Cheaper)
ROE21.20%682.00% Weak
Net Margin8.37%-45016.00% (disorted) Weak
Debt/Equity0.570.42 Weak (High Leverage)
Current Ratio1.154.49 Neutral
ROA8.20%-16121.00% (disorted) Weak

FLMNY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Fielmann AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

70.50%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

75.09%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

66.96%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ